More Avecho Biotechnology Limited news
Avecho Biotechnology LimitedASX: AVE

Phosphagenics Receipt of R&D Tax Incentive

Jan 16, 2018 at 10:13 PM EST · Issued by Avecho Biotechnology Limited

Filed with ASX · Jan 16, 2018 at 10:13 PM EST · 1 page · English

On 6ix: 6ix.com/news/phosphagenics-receipt-of-randd-tax-incentive

Avecho Biotechnology Limited on 6ix

Story so far

  • Receipt of $2.4m R&D Tax IncentiveMar 29, 2016

Earlier from Avecho Biotechnology

  • Phosphagenics Announces Results of Dairy TrialDec 21, 2017
  • TPM Improves Negative Effects of Heat Stress in PoultryDec 14, 2017
  • Phosphagenics Multinational License for TPM in Personal CareDec 3, 2017
  • Phosphagenics Update on TPM/Propofol Development ProgramNov 8, 2017
  • Phosphagenics Entitlement Offer Information BookletOct 3, 2017

Later from Avecho Biotechnology

  • Phosphagenics Placement Secures A$1.37 millionJan 17, 2018
  • Preliminary Final ReportFeb 27, 2018
  • Terumo Shifts Focus From Oxymorphone Patch to InjectablesMar 19, 2018
  • AGM Chairmans Address and CEO PresentationMay 24, 2018
  • Half Year AccountsAug 13, 2018
All Avecho Biotechnology news releases↗

Follow Avecho Biotechnology into a list and get an email when it puts out news.

Follow Avecho Biotechnology
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer